Literature DB >> 9377150

Inhaled nitric oxide in neonates.

N Finer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9377150      PMCID： PMC1720701          DOI： 10.1136/fn.77.2.f81

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  59 in total

1.  Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide.

Authors:  O I Miller; S F Tang; A Keech; D S Celermajer
Journal:  Lancet       Date:  1995-07-01       Impact factor: 79.321

2.  Inhaled nitric oxide treatment for stabilization and emergency medical transport of critically ill newborns and infants.

Authors:  J P Kinsella; J M Schmidt; J Griebel; S H Abman
Journal:  Pediatrics       Date:  1995-05       Impact factor: 7.124

3.  Inhaled nitric oxide for premature infants after prolonged rupture of the membranes.

Authors:  A Peliowski; N N Finer; P C Etches; A J Tierney; C A Ryan
Journal:  J Pediatr       Date:  1995-03       Impact factor: 4.406

4.  Dipyridamole augmentation of response to nitric oxide.

Authors:  J P Kinsella; F Torielli; J W Ziegler; D D Ivy; S H Abman
Journal:  Lancet       Date:  1995-09-02       Impact factor: 79.321

5.  Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response.

Authors:  N N Finer; P C Etches; B Kamstra; A J Tierney; A Peliowski; C A Ryan
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

6.  Prolonged bleeding time during nitric oxide inhalation in the rabbit.

Authors:  M Högman; C Frostell; H Arnberg; B Sandhagen; G Hedenstierna
Journal:  Acta Physiol Scand       Date:  1994-05

7.  Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios.

Authors:  H L Karamanoukian; P L Glick; M Zayek; R H Steinhorn; M S Zwass; J R Fineman; F C Morin
Journal:  Pediatrics       Date:  1994-11       Impact factor: 7.124

8.  Improvement in VA/Q distributions during inhalation of nitric oxide in pigs with methacholine-induced bronchoconstriction.

Authors:  C Putensen; J Räsänen; F A López
Journal:  Am J Respir Crit Care Med       Date:  1995-01       Impact factor: 21.405

9.  The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.

Authors:  K G Thusu; F C Morin; J A Russell; R H Steinhorn
Journal:  Am J Respir Crit Care Med       Date:  1995-11       Impact factor: 21.405

10.  Inhalation of nitric oxide as a treatment of pulmonary hypertension in congenital diaphragmatic hernia.

Authors:  S W Henneberg; S Jepsen; P K Andersen; S A Pedersen
Journal:  J Pediatr Surg       Date:  1995-06       Impact factor: 2.545
View more
  1 in total

1.  Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Delayed Cerebral Ischemia.

Authors:  Christian Fung; Werner J Z'Graggen; Stephan M Jakob; Jan Gralla; Matthias Haenggi; Hans-Ulrich Rothen; Pasquale Mordasini; Michael Lensch; Nicole Söll; Nicole Terpolilli; Sergej Feiler; Markus F Oertel; Andreas Raabe; Nikolaus Plesnila; Jukka Takala; Jürgen Beck
Journal:  Front Neurol       Date:  2022-02-18       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.